Abstract
Summaries for Patients20 November 2001Cost-Effectiveness of Implantable Defibrillators versus the Drug Amiodarone To Prevent Abnormal Heart Rhythms after Heart AttackSearch for more papers by this authorAuthor, Article, and Disclosure Informationhttps://doi.org/10.7326/0003-4819-135-10-200111200-00003 SectionsAboutFull TextPDF ToolsAdd to favoritesDownload CitationsTrack CitationsPermissions ShareFacebookTwitterLinkedInRedditEmail What is the problem and what is known about it so far?After a heart attack, some patients develop a dangerous heart rhythm called sustained ventricular arrhythmia. If the patient is in the hospital, doctors or nurses apply an electric shock to the chest to stop the rhythm (external cardioversion). It is now possible to place a device called an implantable cardioverter defibrillator (ICD), which monitors heart rhythm, inside the chest. When it detects a dangerous rhythm, it applies an electrical shock to restore a normal heart rhythm. The ICD improves the survival of people who have had sustained ventricular ... Author, Article, and Disclosure InformationAffiliations: The summary below is from the full report titled “Potential Cost-Effectiveness of Prophylactic Use of the Implantable Cardioverter Defibrillator or Amiodarone after Myocardial Infarction.” It is in the 20 November 2001 issue of Annals of Internal Medicine (volume 135, pages 870–883). The authors are GD Sanders, MA Hlatky, NR Every, KM McDonald, PA Heidenreich, LS Parsons, and DK Owens.Summaries for Patients are a service provided by Annals to help patients better understand the complicated and often mystifying language of modern medicine.Summaries for Patients are presented for informational purposes only. These summaries are not a substitute for advice from your own medical provider. If you have questions about this material, or need medical advice about your own health or situation, please contact your physician. The summaries may be reproduced for not-for-profit educational purposes only. Any other uses must be approved by the American College of Physicians-American Society of Internal Medicine. PreviousarticleNextarticle Advertisement FiguresReferencesRelatedDetailsSee AlsoPotential Cost-Effectiveness of Prophylactic Use of the Implantable Cardioverter Defibrillator or Amiodarone after Myocardial Infarction Gillian D. Sanders , Mark A. Hlatky , Nathan R. Every , Kathryn M. McDonald , Paul A. Heidenreich , Lori S. Parsons , and Douglas K. Owens Metrics 20 November 2001Volume 135, Issue 10Page: I-56KeywordsArrhythmiaDrugsHeartHeart failureImplantable cardioverter defibrillatorsMyocardial infarctionQuality adjusted life yearsShockSimulation and modelingThorax ePublished: 20 November 2001 Issue Published: 20 November 2001 Copyright & PermissionsCopyright © 2001 by American College of Physicians. All Rights Reserved.PDF downloadLoading ...
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
